Intention to participate in COVID-19 vaccine clinical trials in May 2021: a cross-sectional survey in the general French population

References

• Bok K, Sitar S, Graham BS, Mascola JR. Accelerated COVID-19 vaccine development: milestones, lessons, and prospects. Immunity. 2021;54(8):1636‑51. doi:10.1016/j.immuni.2021.07.017.
   PubMed Web of Science ®Google Scholar
• Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020;38(45):7002‑6. doi:10.1016/j.vaccine.2020.09.041.
   PubMed Web of Science ®Google Scholar
• Sambourg J, Bonneton M, Luong Nguyen L, Trillou C, Dohou J, Saint-Lary O, et al. Demographic characteristics and COVID-19 risk factors of volunteers registered on COVIREIVAC, the French national platform for COVID-19 vaccine trials. 31st European Congress of Clinical Mircobiology and Infectious Diseases; 2021 Jul.
   Google Scholar
• Krause PR, Fleming TR, Longini IM, Peto R, Briand S, Heymann DL, Beral V, Snape MD, Rees H, Ropero A-M, et al. SARS-CoV-2 variants and vaccines. N Engl J Med. 2021;385(2):179‑86. doi:10.1056/NEJMsr2105280.
   Web of Science ®Google Scholar
• Géodes - Santé publique France - Indicateurs : cartes, données et graphiques [Internet]. [accessed 2021 Oct 18]. https://geodes.santepubliquefrance.fr/#c=indicator&i=vacsi12.couv_dose1&s=2021-07-01&t=a01&view=map2
   Google Scholar
• Cobb EM, Singer DC, Davis MM. Public interest in medical research participation: differences by volunteer status and study type. Clin Transl Sci. 2014;7(2):145‑9. doi:10.1111/cts.12142.
   PubMed Web of Science ®Google Scholar
• Detoc M, Launay O, Dualé C, Mutter C, Le Huec J-C, Lenzi N, Lucht F, Gagneux-Brunon A, Botelho-Nevers E. Barriers and motivations for participation in preventive vaccine clinical trials: experience of 5 clinical research sites. Vaccine. 2019;37(44):6633‑9. doi:10.1016/j.vaccine.2019.09.048.
   PubMed Web of Science ®Google Scholar
• Algan Y, Cohen D, Davoine E, Foucault M, Stantcheva S. Trust in scientists in times of pandemic: panel evidence from 12 countries. PNAS. 2021;118(40):e2108576118. [accessed 2021 Oct 1]. https://www.pnas.org/content/118/40/e2108576118
   PubMed Web of Science ®Google Scholar
• Sondage national « Les Français et la science » | science-and-you.Com [Internet]. [accessed 2021 Dec 27]. http://www.science-and-you.com/fr/sondage2021
   Google Scholar
• The state of vaccine confidence in the EU: 2018: the vaccine confidence project [Internet]. [accessed 2019 oct 2]. https://www.vaccineconfidence.org/research/the-state-of-vaccine-confidence-in-the-eu-2018/
   Google Scholar
• Thompson HS, Manning M, Mitchell J, Kim S, Harper FWK, Cresswell S, Johns K, Pal S, Dowe B, Tariq M, et al. Factors associated with racial/ethnic group–based medical mistrust and perspectives on COVID-19 vaccine trial participation and vaccine uptake in the US. JAMA Netw Open. 2021;4(5):e2111629. doi:10.1001/jamanetworkopen.2021.11629.
   PubMed Web of Science ®Google Scholar
• Sethi S, Kumar A, Mandal A, Shaikh M, Hall CA, Kirk JMW, Moss P, Brookes MJ, Basu S. The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond. Trials. 2021;22(1):296. doi:10.1186/s13063-021-05250-4.
   PubMed Web of Science ®Google Scholar
• Schultz É, Ward JK, Atlani-Duault L, Holmes SM, Mancini J. French public familiarity and attitudes toward clinical research during the COVID-19 pandemic. Int J Environ Res Public Health. 2021;18(5):2611. doi:10.3390/ijerph18052611.
   PubMed Web of Science ®Google Scholar
• Pahus L, Suehs CM, Halimi L, Bourdin A, Chanez P, Jaffuel D, Marciano J, Gamez A-S, Vachier I, Molinari N, et al. Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials? BMC Med Ethics. 2020;21(1):72. doi:10.1186/s12910-020-00509-y.
   PubMed Web of Science ®Google Scholar
• Sisco MR, Weber EU. Examining charitable giving in real-world online donations. Nat Commun. 2019;10:3968. doi:10.1038/s41467-019-11852-z.
   PubMed Web of Science ®Google Scholar
• Ridda I, MacIntyre CR, Lindley RI, Tan TC. Difficulties in recruiting older people in clinical trials: an examination of barriers and solutions. Vaccine. 2010;28(4):901‑6. doi:10.1016/j.vaccine.2009.10.081.
   Web of Science ®Google Scholar
• Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934‑43. doi:10.1001/jamainternmed.2020.0994.
   Web of Science ®Google Scholar
• Abu Jabal K, Ben-Amram H, Beiruti K, Batheesh Y, Sussan C, Zarka S, Edelstein M. Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021. Euro Surveill. 2021;26(6). doi:10.2807/1560-7917.ES.2021.26.6.2100096
   PubMedGoogle Scholar
• Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403‑16. doi:10.1056/NEJMoa2035389.
   Web of Science ®Google Scholar
• Labetoulle R, Detoc M, Gagnaire J, Berthelot P, Pelissier C, Fontana L, Botelho-Nevers E, Gagneux-Brunon A. COVID-19 in health-care workers: lessons from SARS and MERS epidemics and perspectives for chemoprophylaxis and vaccines. Expert Rev Vaccines. 2020;19(10):937‑47. doi:10.1080/14760584.2020.1843432.
   PubMed Web of Science ®Google Scholar
• Kitonsa J, Kamacooko O, Bahemuka UM, Kibengo F, Kakande A, Wajja A, Basajja V, Lumala A, Ssemwanga E, Asaba R, et al. Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda. Plos One. 2021;16(5):e0251992. doi:10.1371/journal.pone.0251992.
   PubMed Web of Science ®Google Scholar
• Ward JK, Alleaume C, Peretti-Watel P, Peretti-Watel P, Seror V, Cortaredona S, Launay O, Raude J, Verger P, Beck F, et al. The French public’s attitudes to a future COVID-19 vaccine: the politicization of a public health issue. Soc Sci Med. 2020;265:113414. doi:10.1016/j.socscimed.2020.113414.
   PubMed Web of Science ®Google Scholar
• Detoc M, Gagneux-Brunon A, Lucht F, Botelho-Nevers E. Barriers and motivations to volunteers’ participation in preventive vaccine trials: a systematic review. Expert Rev Vaccines. 2017 ;16(5):467‑77. doi:10.1080/14760584.2017.1297706.
   PubMed Web of Science ®Google Scholar
• Abdelhafiz AS, Abd ElHafeez S, Khalil MA, Shahrouri M, Alosaim B, Salem RO, Alorabi M, Abdelgawad F, Ahram M. Factors influencing participation in COVID-19 clinical trials: a multi-national study. Front Med. 2021;8:155. doi:10.3389/fmed.2021.608959.
   Web of Science ®Google Scholar
• Detoc M, Touche C, Charles R, Lucht F, Gagneux-Brunon A, Botelho-Nevers E. Primary physicians’ attitudes toward their patients receiving a proposal to participate in a vaccine trial. Hum Vaccin Immunother. 2019;15(12):2969‑79. doi:10.1080/21645515.2019.1625646.
   PubMed Web of Science ®Google Scholar
• Grimm P. Social desirability bias. In: Wiley International Encyclopedia of Marketing [Internet]. John Wiley & Sons, Ltd; 2010. [accessed 2021 Dec 28]. https://onlinelibrary.wiley.com/doi/abs/10.1002/9781444316568.wiem02057
   Google Scholar
• Timmons S, McGinnity F, Belton C, Barjaková M, Lunn P. It depends on how you ask: measuring bias in population surveys of compliance with COVID-19 public health guidance. J Epidemiol Community Health. 2021;75(4):387‑9. doi:10.1136/jech-2020-215256.
   Web of Science ®Google Scholar